Literature DB >> 16086671

Triosephosphate isomerase deficiency: consequences of an inherited mutation at mRNA, protein and metabolic levels.

Judit Oláh1, Ferenc Orosz, László G Puskás, László Hackler, Margit Horányi, László Polgár, Susan Hollán, Judit Ovádi.   

Abstract

Triosephosphate isomerase (TPI) deficiency is a unique glycolytic enzymopathy coupled with neurodegeneration. Two Hungarian compound heterozygote brothers inherited the same TPI mutations (F240L and E145Stop), but only the younger one suffers from neurodegeneration. In the present study, we determined the kinetic parameters of key glycolytic enzymes including the mutant TPI for rational modelling of erythrocyte glycolysis. We found that a low TPI activity in the mutant cells (lower than predicted from the protein level and specific activity of the purified recombinant enzyme) is coupled with an increase in the activities of glycolytic kinases. The modelling rendered it possible to establish the steady-state flux of the glycolysis and metabolite concentrations, which was not possible experimentally due to the inactivation of the mutant TPI and other enzymes during the pre-steady state. Our results showed that the flux was 2.5-fold higher and the concentration of DHAP (dihydroxyacetone phosphate) and fructose 1,6-bisphosphate increased 40- and 5-fold respectively in the erythrocytes of the patient compared with the control. Although the rapid equilibration of triosephosphates is not achieved, the energy state of the cells is not 'sick' due to the activation of key regulatory enzymes. In lymphocytes of the two brothers, the TPI activity was also lower (20%) than that of controls; however, the remaining activity was high enough to maintain the rapid equilibration of triosephosphates; consequently, no accumulation of DHAP occurs, as judged by our experimental and computational data. Interestingly, we found significant differences in the mRNA levels of the brothers for TPI and some other, apparently unrelated, proteins. One of them is the prolyl oligopeptidase, the activity decrease of which has been reported in well-characterized neurodegenerative diseases. We found that the peptidase activity of the affected brother was reduced by 30% compared with that of his neurologically intact brother.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086671      PMCID: PMC1316309          DOI: 10.1042/BJ20050993

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

Authors:  Yee Hwa Yang; Sandrine Dudoit; Percy Luu; David M Lin; Vivian Peng; John Ngai; Terence P Speed
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

3.  Enhanced association of mutant triosephosphate isomerase to red cell membranes and to brain microtubules.

Authors:  F Orosz; G Wágner; K Liliom; J Kovács; K Baróti; M Horányi; T Farkas; S Hollán; J Ovádi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

4.  Recovery of cyanine-dye nucleotide triphosphates.

Authors:  László G Puskás; László Hackler; Györgyi Kovács; Zoltán Kupihár; Agnes Zvara; Tamás Micsik; Paul van Hummelen
Journal:  Anal Biochem       Date:  2002-06-15       Impact factor: 3.365

5.  Lack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination.

Authors:  M Coma; F X Guix; I Uribesalgo; G Espuña; M Solé; D Andreu; F J Muñoz
Journal:  Brain       Date:  2005-04-07       Impact factor: 13.501

6.  Diminished blood levels of reduced glutathione and alpha-tocopherol in two triosephosphate isomerase-deficient brothers.

Authors:  E Karg; I Németh; M Horányi; S Pintér; L Vécsei; S Hollán
Journal:  Blood Cells Mol Dis       Date:  2000-02       Impact factor: 3.039

7.  Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: molecular basis of enzyme deficiency.

Authors:  F Orosz; J Oláh; M Alvarez; G M Keseru; B Szabó; G Wágner; Z Kovári; M Horányi; K Baróti; J A Martial; S Hollán; J Ovádi
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

8.  Identical germ-line mutations in the triosephosphate isomerase alleles of two brothers are associated with distinct clinical phenotypes.

Authors:  C Valentin; M Cohen-Solal; L Maquat; M Horányi; M Inselt-Kovács; S Hollán
Journal:  C R Acad Sci III       Date:  2000-03

Review 9.  Triosephosphate isomerase deficiency: historical perspectives and molecular aspects.

Authors:  A S Schneider
Journal:  Baillieres Best Pract Res Clin Haematol       Date:  2000-03

Review 10.  Triosephosphate isomerase deficiency: a neurodegenerative misfolding disease.

Authors:  Judit Oláh; Ferenc Orosz; György M Keserü; Zoltán Kovári; János Kovács; Susan Hollán; Judit Ovádi
Journal:  Biochem Soc Trans       Date:  2002-04       Impact factor: 5.407

View more
  10 in total

1.  Drosophila model of human inherited triosephosphate isomerase deficiency glycolytic enzymopathy.

Authors:  Alicia M Celotto; Adam C Frank; Jacquelyn L Seigle; Michael J Palladino
Journal:  Genetics       Date:  2006-09-15       Impact factor: 4.562

2.  A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases.

Authors:  Krishnakumar N Menon; David L Steer; Martin Short; Steven Petratos; Ian Smith; Claude C A Bernard
Journal:  Mol Cell Proteomics       Date:  2011-03-18       Impact factor: 5.911

3.  Triosephosphate isomerase I170V alters catalytic site, enhances stability and induces pathology in a Drosophila model of TPI deficiency.

Authors:  Bartholomew P Roland; Christopher G Amrich; Charles J Kammerer; Kimberly A Stuchul; Samantha B Larsen; Sascha Rode; Anoshé A Aslam; Annie Heroux; Ronald Wetzel; Andrew P VanDemark; Michael J Palladino
Journal:  Biochim Biophys Acta       Date:  2014-10-16

4.  Degradation of functional triose phosphate isomerase protein underlies sugarkill pathology.

Authors:  Jacquelyn L Seigle; Alicia M Celotto; Michael J Palladino
Journal:  Genetics       Date:  2008-05-05       Impact factor: 4.562

5.  A proteomic analysis of the ventral hippocampus of rats subjected to maternal separation and escitalopram treatment.

Authors:  Lelanie Marais; Suzél M Hattingh; Dan J Stein; Willie M U Daniels
Journal:  Metab Brain Dis       Date:  2009-10-16       Impact factor: 3.584

6.  The plastid isoform of triose phosphate isomerase is required for the postgerminative transition from heterotrophic to autotrophic growth in Arabidopsis.

Authors:  Mingjie Chen; Jay J Thelen
Journal:  Plant Cell       Date:  2010-01-22       Impact factor: 11.277

7.  Triose phosphate isomerase deficiency is caused by altered dimerization--not catalytic inactivity--of the mutant enzymes.

Authors:  Markus Ralser; Gino Heeren; Michael Breitenbach; Hans Lehrach; Sylvia Krobitsch
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

8.  Fructose-1,6-Bisphosphate Protects Hippocampal Rat Slices from NMDA Excitotoxicity.

Authors:  Kamal M Yakoub; Giacomo Lazzarino; Angela M Amorini; Giuseppe Caruso; Concetta Scazzone; Marcello Ciaccio; Barbara Tavazzi; Giuseppe Lazzarino; Antonio Belli; Valentina Di Pietro
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

9.  Bone marrow transplantation corrects haemolytic anaemia in a novel ENU mutagenesis mouse model of TPI deficiency.

Authors:  Ashlee J Conway; Fiona C Brown; Elinor J Hortle; Gaetan Burgio; Simon J Foote; Craig J Morton; Stephen M Jane; David J Curtis
Journal:  Dis Model Mech       Date:  2018-05-21       Impact factor: 5.758

10.  Structural Analysis of an Epitope Candidate of Triosephosphate Isomerase in Opisthorchis viverrini.

Authors:  Jonghyeon Son; Sulhee Kim; So Eun Kim; Haemin Lee; Myoung-Ro Lee; Kwang Yeon Hwang
Journal:  Sci Rep       Date:  2018-10-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.